108-109年度食品摻加西藥檢驗案件分析   全文下載

Analysis on Pharmaceutical Adulterants in Dietary Supplements Cases from 2019 to 2020

食品藥物管理署於108-109年度受理食品摻加西藥檢驗案件共計675件檢體，其中268件檢出西藥成分，檢出率為39.7%。依受理案件類別統計，屬縣市政府衛生局轉送消費者申請案件及司法檢警調海關等機關送驗之服務案件有600件，檢出248件（41.3%）；屬衛生行政機關送驗之抽查案件有75件，檢出20件（26.7%）。依檢體標示或送驗單位指定之檢驗類別進行統計，檢出件數最多者為補腎滋養類（壯陽類）（204件），其次為減肥類（57件）。依檢出成分頻率排序，前3名依序為sildenafil、sibutramine及tadalafil。檢出成分除了一般西藥成分外，108至109年度亦檢出壯陽西藥成分sildenafil及tadalafil類緣物共7種，相關檢驗結果及趨勢分析可提供行政管理單位制定政策之參考。

This report summarized the results of 675 samples of commercial dietary supplements received from 2019 to 2020 and analyzed for the presence of pharmaceutical adulterants. The results showed that 39.7% (268/675) of the samples were adulterated. Among them, six hundred samples from consumer service centers of the local health authorities and other governmental institutions were found 41.3% (248/600) adulterated. The 75 inspection samples from local health authorities were found 26.7% (20/75) adulterated. The most adulterated supplements, were used for erectile dysfunction (204 samples) and weight loss (57 samples). The top three adulterants found were sildenafil, sibutramine and tadalafil. In addition to pharmaceutical chemicals, seven analogues of sildenafil and tadalafil were found. This report will be provided to the administrative authorities as reference for policy making.